Canadian Medical Center Co. (4021) is listed on Tadawul of the Saudi Exchange (Tadawul) under sector Health Care Equipment & Svc. Financial data sourced from CMA-mandated XBRL filings via Sahm Screener (sahmscreener.com).

For fiscal year 2025, Canadian Medical Center Co. reported revenue of SAR 148M, net profit of SAR 10M, and earnings per share of SAR 0.14. Total assets stood at SAR 133M with total equity of SAR 96M and total liabilities of SAR 37M.

Operating cash flow for 2025 was SAR 20M, representing a cash conversion ratio of 1.89 relative to net profit. Free cash flow was SAR 11M.

Earnings quality analysis by Sahm Screener: Of every SAR 1.00 in reported net profit for 2025, SAR 1.89 arrived as operating cash. This indicates Exceptional quality earnings based on the cash conversion ratio of 1.89.

Revenue growth from 2024 to 2025: +33.8%. Net profit growth over the same period: +2.2%. 3-year revenue CAGR: 56.0%. 3-year net profit CAGR: -12.5%.

Key financial ratios for 2025: Return on Equity 10.9%, Return on Assets 7.9%, Net Margin 7.1%, Debt to Equity 0.38.

In 2024, Canadian Medical Center Co. reported revenue of SAR 111M and net profit of SAR 10M, compared to SAR 148M and SAR 10M respectively in 2025.